Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

231.09
-7.1600-3.01%
Post-market: 230.80-0.2920-0.13%18:25 EDT
Volume:913.66K
Turnover:213.81M
Market Cap:16.63B
PE:34.03
High:240.44
Open:237.26
Low:231.05
Close:238.25
52wk High:322.34
52wk Low:187.43
Shares:71.94M
Float Shares:71.41M
Volume Ratio:0.97
T/O Rate:1.28%
Dividend:0.85
Dividend Rate:0.37%
EPS(TTM):6.79
EPS(LYR):6.79
ROE:16.85%
ROA:10.09%
PB:5.23
PE(LYR):34.03

Loading ...

West Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Oct 24, 2025

BUZZ-U.S. STOCKS ON THE MOVE-LendingClub, Hasbro, Intel

Reuters
·
Oct 24, 2025

Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $350, Maintains Outperform Rating

MT Newswires Live
·
Oct 24, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Lam Research, Rivian Automotive, Eli Lilly

Reuters
·
Oct 24, 2025

Early notable gainers among liquid option names on October 23rd

TIPRANKS
·
Oct 23, 2025

Stock Track | West Pharmaceutical Soars 9.41% on Strong Q3 Results and Raised 2025 Outlook

Stock Track
·
Oct 23, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Blackstone, Darling Ingredients, Harmony Biosciences

Reuters
·
Oct 23, 2025

West Pharmaceutical Services Reports Strong Q3 2025 Results

TIPRANKS
·
Oct 23, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Ventyx Biosciences, Dow, Las Vegas

Reuters
·
Oct 23, 2025

West Pharmaceutical Shares Rise 6.6% Premarket After Co Lifts Annual Profit Forecast

THOMSON REUTERS
·
Oct 23, 2025

Stock Track | West Pharmaceutical Soars 6.50% Pre-market on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Oct 23, 2025

West Pharma boosts annual profit forecast on strong demand for its drug components

Reuters
·
Oct 23, 2025

West Pharmaceutical ups FY25 adjusted EPS view to $7.06-$7.11 from $6.65-$6.85

TIPRANKS
·
Oct 23, 2025

West Pharmaceutical Servs Q3 Adj. EPS $1.96 Beats $1.68 Estimate, Sales $804.600M Beat $787.929M Estimate

Benzinga
·
Oct 23, 2025

West Pharmaceutical Services Inc Q4 Shr View $1.78, REV View $796.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Oct 23, 2025

West Pharmaceutical Services: Q4 2025 Financial Guidance Reported Net Sales Growth Anticipated to Be in Range of 5.5% to 6.8%

THOMSON REUTERS
·
Oct 23, 2025

West Pharmaceutical Services Inc: Expects Fourth-Quarter 2025 Adjusted-Diluted EPS Guidance Range of $1.81 to $1.86

THOMSON REUTERS
·
Oct 23, 2025

West Pharmaceutical Services Inc: Expects Fourth-Quarter 2025 Net Sales Guidance Range of $790 Mln to $800 Mln

THOMSON REUTERS
·
Oct 23, 2025

Corrected-West Pharmaceutical: FY Adj EPS Guidance Range Raised From $6.65 to $6.85 Earlier (Not ‘FY EPS USD 6.65-6.85’)

THOMSON REUTERS
·
Oct 23, 2025

West Pharmaceutical Outlook FY Adjusted EPS USD 7.06-7.11

THOMSON REUTERS
·
Oct 23, 2025